Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024

EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Change in Forecast
Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024

07-May-2024 / 21:19 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024


Fresenius raises its full-year outlook due to the excellent first quarter
and a better than originally expected operating performance for the
remainder of the fiscal year 2024.

Fresenius now expects organic group revenue growth between 4 and 7% for the
fiscal year 2024 (previously: 3 to 6%). Group EBIT at constant currency is
now expected to grow between 6 and 10% (previously: 4 to 8%).

The increase of the group outlook is based on improved business prospects
for Fresenius Kabi. Fresenius Kabi now expects organic revenue growth in the
mid to high single-digit percentage range for fiscal year 2024 (previously:
mid single-digit percentage range). The EBIT margin is now expected to range
between 15 and 16% (previously: around 15%).

The adjustment of the group outlook also reflects the fact that the forecast
is now provided without Fresenius Vamed, i.e. exclusively for the operating
companies Fresenius Kabi and Fresenius Helios. Following the announcement of
the planned divestment of Fresenius Vamed's rehabilitation business,
Fresenius has initiated its structured exit from its investment company
Fresenius Vamed.



For additional information on the performance indicators used please refer
to our website at
https://www.fresenius.com/alternative-performance-measures.


Fresenius SE & Co. KGaA,
represented by Fresenius Management SE,
The Management Board

Bad Homburg v.d.H., May 7, 2024

----------------------------------------
Contact:
Markus Georgi
Senior Vice President Investor Relations
T: +49 (0) 6172 608-2485
markus.georgi@fresenius.com
----------------------------------------

End of Note


End of Inside Information

---------------------------------------------------------------------------

07-May-2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        Fresenius SE & Co. KGaA
                   Else-Kröner-Straße 1
                   61352 Bad Homburg v.d.H.
                   Germany
   Phone:          +49 (0)6172 608-2485
   Fax:            +49 (0)6172 608-2488
   E-mail:         ir-fre@fresenius.com
   Internet:       www.fresenius.com
   ISIN:           DE0005785604
   WKN:            578560
   Indices:        DAX
   Listed:         Regulated Market in Dusseldorf, Frankfurt (Prime
                   Standard), Munich; Regulated Unofficial Market in
                   Berlin, Hamburg, Hanover, Stuttgart, Tradegate
                   Exchange; Luxembourg Stock Exchange
   EQS News ID:    1898031

End of Announcement EQS News Service
---------------------------------------------------------------------------

1898031 07-May-2024 CET/CEST